glp 1 meds and alcohol consumption Physiological perceptual effects of GLP-1 receptor agonists during in people with obesity: a pilot study How GLP-1 Drugs Are Impacting

One study in Diabetes, Obesity, and Metabolism regained two-thirds of the weight theyd lost while on the drug, and similarly reversed any improvements in their cardiovascular health

2 Cardiovascular Benefits: Research has shown that some GLP-1 agonists, such as liraglutide and semaglutide, reduce major adverse cardiovascular events in people with type 2 diabetes

Persistent hunger despite optimised dosing and lifestyle measures warrants clinical review to consider alternative GLP-1 agonists, other pharmacotherapy, specialist weight management services, or bariatric surgery

Notably, North Carolina removed and subsequently reinstated coverage between August 2024 and January 2025

Anti-inflammatory effects of yerba mate extract on colon carcinogenesis